• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vaccine Breakthrough Infections with SARS-CoV-2 Variants.

作者信息

Rana Kirtan, Mohindra Ritin, Pinnaka Lakshmi

机构信息

Postgraduate Institute of Medical Education and Research, Chandigarh, India

出版信息

N Engl J Med. 2021 Jul 8;385(2):e7. doi: 10.1056/NEJMc2107808. Epub 2021 Jun 2.

DOI:10.1056/NEJMc2107808
PMID:34077641
Abstract
摘要

相似文献

1
Vaccine Breakthrough Infections with SARS-CoV-2 Variants.感染新冠病毒变异株的疫苗突破性感染
N Engl J Med. 2021 Jul 8;385(2):e7. doi: 10.1056/NEJMc2107808. Epub 2021 Jun 2.
2
Vaccine Breakthrough Infections with SARS-CoV-2 Variants.感染新冠病毒变异株的疫苗突破性感染
N Engl J Med. 2021 Jul 8;385(2):e7. doi: 10.1056/NEJMc2107808. Epub 2021 Jun 2.
3
Vaccine Breakthrough Infections with SARS-CoV-2 Variants. Reply.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变异株的疫苗突破性感染。回复。
N Engl J Med. 2021 Jul 8;385(2):e7. doi: 10.1056/NEJMc2107808. Epub 2021 Jun 2.
4
Identification of SARS-CoV-2 variants of concern in vaccine-breakthrough infections.在疫苗突破性感染中识别值得关注的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体。
J Infect Dev Ctries. 2022 Apr 30;16(4):580-582. doi: 10.3855/jidc.15458.
5
How to Deal With Vaccine Breakthrough Infection With SARS-CoV-2 Variants.如何应对 SARS-CoV-2 变异株的疫苗突破性感染。
Front Public Health. 2022 Mar 15;10:842303. doi: 10.3389/fpubh.2022.842303. eCollection 2022.
6
Breakthrough SARS-CoV-2 infections after COVID-19 immunization.突破性 SARS-CoV-2 感染 COVID-19 免疫后。
J Investig Med. 2022 Aug;70(6):1429-1432. doi: 10.1136/jim-2021-002131. Epub 2022 Jun 29.
7
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.加利福尼亚州旧金山湾区疫苗突破性病例中抗体耐药的 SARS-CoV-2 变异株占优势。
Nat Microbiol. 2022 Feb;7(2):277-288. doi: 10.1038/s41564-021-01041-4. Epub 2022 Jan 10.
8
Variants of Concern Are Overrepresented Among Postvaccination Breakthrough Infections of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Washington State.在华盛顿州，严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 疫苗接种后突破性感染中，关注变体的比例过高。
Clin Infect Dis. 2022 Mar 23;74(6):1089-1092. doi: 10.1093/cid/ciab581.
9
Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.引发 SARS-CoV-2 疫苗突破性感染的关注变体来自印度。
J Med Virol. 2022 Apr;94(4):1696-1700. doi: 10.1002/jmv.27461. Epub 2021 Nov 25.
10
How easy will it really be to replicate the success of the covid-19 vaccine with neglected infectious diseases?要利用被忽视的传染病复制新冠疫苗的成功究竟会有多容易？
BMJ. 2021 Mar 10;372:n678. doi: 10.1136/bmj.n678.

引用本文的文献

1
Assessing breakthrough infections: Covishield (late schedule) versus Covaxin - A prospective comparative analysis in the general population.评估突破性感染：Covishield（延迟接种方案）与Covaxin——普通人群中的前瞻性比较分析
J Family Med Prim Care. 2025 Jun;14(6):2307-2312. doi: 10.4103/jfmpc.jfmpc_1714_24. Epub 2025 Jun 6.
2
Sequential Immunization with Vaccines Based on SARS-CoV-2 Virus-like Particles Induces Broadly Neutralizing Antibodies.基于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒样颗粒的疫苗序贯免疫诱导广泛中和抗体。
Vaccines (Basel). 2024 Aug 19;12(8):927. doi: 10.3390/vaccines12080927.
3
Severity of respiratory illness among Covid-19-vaccinated and non-vaccinated admitted patients-An observational study from a teaching hospital of Tripura.
新冠肺炎疫苗接种者与未接种者中住院患者的呼吸道疾病严重程度——来自特里普拉一所教学医院的观察性研究
J Family Med Prim Care. 2024 May;13(5):2111-2115. doi: 10.4103/jfmpc.jfmpc_1643_23. Epub 2024 May 24.
4
Determining the Time of Booster Dose Based on the Half-Life and Neutralization Titers against SARS-CoV-2 Variants of Concern in Fully Vaccinated Individuals.根据完全接种疫苗者对 SARS-CoV-2 关注变异株的半衰期和中和滴度来确定加强针的接种时间。
Microbiol Spectr. 2023 Aug 17;11(4):e0408122. doi: 10.1128/spectrum.04081-22. Epub 2023 Jul 10.
5
Vaccination and COVID-19 positivity rates in a network of eye hospitals in Southern and Eastern India during the second wave of COVID-19.印度南部和东部眼科医院网络在新冠疫情第二波期间的疫苗接种情况及新冠病毒检测阳性率
Indian J Ophthalmol. 2023 Jul;71(7):2920-2922. doi: 10.4103/IJO.IJO_414_23.
6
Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants.灭活疫苗诱导产生的强效抗体可以广泛中和流行的 SARS-CoV-2 变异株。
Nat Commun. 2023 Apr 17;14(1):2179. doi: 10.1038/s41467-023-37926-7.
7
Genomic surveillance of SARS-CoV-2 in COVID-19 vaccinated healthcare workers in Lebanon.黎巴嫩 COVID-19 疫苗接种医护人员中 SARS-CoV-2 的基因组监测。
BMC Med Genomics. 2023 Jan 27;16(1):14. doi: 10.1186/s12920-023-01443-9.
8
Identification of severe acute respiratory syndrome coronavirus 2 breakthrough infections by anti-nucleocapsid antibody among fully vaccinated non-healthcare workers during the transition from the delta to omicron wave.在从德尔塔毒株流行期过渡到奥密克戎毒株流行期期间，通过抗核衣壳抗体在完全接种疫苗的非医护人员中识别严重急性呼吸综合征冠状病毒2突破性感染情况。
Front Med (Lausanne). 2022 Nov 29;9:1019490. doi: 10.3389/fmed.2022.1019490. eCollection 2022.
9
Severe acute respiratory syndrome coronavirus 2 vaccine breakthrough infections: A single metro-based testing network experience.严重急性呼吸综合征冠状病毒2型疫苗突破性感染：基于单一城市的检测网络经验
Front Med (Lausanne). 2022 Nov 25;9:1031083. doi: 10.3389/fmed.2022.1031083. eCollection 2022.
10
Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model.COVAXIN®在仓鼠模型中对Delta和Omicron变体的保护效力。
iScience. 2022 Oct 21;25(10):105178. doi: 10.1016/j.isci.2022.105178. Epub 2022 Sep 22.